Form EFFECT AMICUS THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016982 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CREMX Completes Latest Quarterly Repurchase Offer Following Three-Year Anniversary and Expanded Platform Access
- ZEISS Helps Manufacturers Find Certainty at IMTS 2026
- K2view positioned as a Leader in the SPARK Matrix™: Data Masking, Tokenization, and Synthetic Data Solutions, 2026 by QKS Group
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
